Showing results (1-10 of 940) with videos related to
Sort By:
Pageof 94
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 24, 2004
[Regulatory T cells and inflammatory bowel diseases]Takanori Kanai, Mamoru WatanabeExpert Opinion on Biological Therapy|June 7, 2005
Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseasesTakanori Kanai, Mamoru WatanabeJournal of Gastroenterology|April 18, 2003
Mucosal T cells as a target for treatment of IBDMamoru Watanabe, Motomi Yamazaki, Takanori KanaiExpert Opinion on Biological Therapy|April 14, 2006
The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel diseaseTakanori Kanai, Toshifumi Hibi, Mamoru WatanabeThe Keio Journal of Medicine|December 29, 2009
Systemically circulating colitogenic memory CD4+T cells may be an ideal target for the treatment of inflammatory bowel diseasesTakanori Kanai, Mamoru Watanabe, Toshifumi HibiDigestion|February 8, 2008
Current pharmacologic therapies and emerging alternatives in the treatment of ulcerative colitisTetsuya Nakamura, Masakazu Nagahori, Takanori Kanai, et al.Journal of Gastroenterology|February 8, 2003
ICOS costimulation in inflammatory bowel diseaseTakanori Kanai, Teruji Totsuka, Katsunari Tezuka, et al.Gastroenterology|January 24, 2007
Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancerKiichiro Tsuchiya, Tetsuya Nakamura, Ryuichi Okamoto, et al.Inflammatory Bowel Diseases|November 15, 2008
Persistent retention of colitogenic CD4+ memory T cells causes inflammatory bowel diseases to become intractableTakanori Kanai, Yasuhiro Nemoto, Takayuki Tomita, et al.Current Drug Targets. Inflammation and Allergy|October 17, 2003
Therapeutic approaches to chronic intestinal inflammation by specific targeting of mucosal IL-7/IL-7R signal pathwayMamoru Watanabe, Motomi Yamazaki, Ryuichi Okamoto, et al.Pageof 94